Home › Funds › 683 Capital Management, LLC › TRAX
683 Capital Management, LLC position in TRAX
FIRST TRACKS BIOTHERAPEUTICS ORD SHS · Health Care
683 Capital Management, LLC reported holding 750,000 shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS ORD SHS) in its Q2 2026 13F filing — a position valued at US$15.1M, representing 0.80% of its reported portfolio and ranking #27 among its reported holdings. 683 Capital Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 683 Capital Management, LLC's TRAX position evolved
683 Capital Management, LLC first disclosed a stake in TRAX in Q2 2026 at 750,000 shares (US$15.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 750.00K | $15.09M | New |
About TRAX and 13F data
TRAX (FIRST TRACKS BIOTHERAPEUTICS ORD SHS) is a Health Care company. 154 other funds we track also report a position in TRAX — the largest reported positions include EcoR1 Capital, LLC (US$63.9M), TCG Crossover Management, LLC (US$58.3M), Affinity Asset Advisors, LLC (US$40.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRAX
- EcoR1 Capital, LLC 3.17M sh · $63.87M · Q2 2026
- TCG Crossover Management, LLC 2.90M sh · $58.25M · Q2 2026
- Affinity Asset Advisors, LLC 2.03M sh · $40.88M · Q2 2026
- Trails Edge Capital Partners, LP 1.51M sh · $30.46M · Q2 2026
- Vestal Point Capital, LP 1.01M sh · $20.38M · Q2 2026
- Sanofi 821.92K sh · $16.54M · Q2 2026
- STEMPOINT CAPITAL LP 622.72K sh · $12.53M · Q2 2026
- Palo Alto Investors LP 603.49K sh · $12.14M · Q2 2026
- Sofinnova Investments, Inc. 565.20K sh · $11.37M · Q2 2026
- Ally Bridge Group (NY) LLC 284.29K sh · $5.72M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 226.00K sh · $4.55M · Q2 2026
- Opaleye Management Inc. 65.00K sh · $1.31M · Q2 2026
More on 683 Capital Management, LLC
FAQ
How long has 683 Capital Management, LLC held TRAX?
683 Capital Management, LLC has disclosed TRAX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is 683 Capital Management, LLC's current position in TRAX?
As of Q2 2026, 683 Capital Management, LLC holds 750.00K shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS ORD SHS), valued at $15.09M, representing 0.80% of its reported portfolio and ranking #27.
Has 683 Capital Management, LLC been buying or selling TRAX?
In the latest 13F filing (Q2 2026), 683 Capital Management, LLC newly opened its position in TRAX.
Which other funds hold TRAX?
Other major institutional holders of TRAX include EcoR1 Capital, LLC, TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, among 154 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.